The IDSA published guidelines for the treatment of patients with Clostridioides difficile infection in 2018. But which of the recommended treatment regimens is most cost-effective? Researchers have the...
After identifying 3 neuroprotective drugs acting on different axonal pathobiologies, the researchers assessed each drug’s efficacy on percentage brain volume change among patients with secondary progressive...
Previous studies have demonstrated that triple upfront combination therapy is an effective treatment for patients with severe pulmonary arterial hypertension. But what is the therapy’s impact on right...
The authors of a new study sought to determine whether H pylori eradication treatment reduces the risk of gastric cancer among those with a family history of gastric cancer in first-degree relatives.
Little is known about the racial/ethnic differences among patients with pulmonary arterial hypertension. Therefore, the researchers investigated these differences as well as how the effects of ancestry...
Authors of the MEASURE 3 study have shared their end‐of‐study 3‐year efficacy and safety results of secukinumab, 150 mg and 300 mg, among patients with active ankylosing spondylitis. Find out what the...
Jessica Ailani, MD, answers our questions about new developments in therapeutics and technology, as well as overcoming the challenges of diagnosing and treating migraine.
Because less-invasive, nonsurgical approaches are needed to treat severe emphysema, authors of a new study compared the safety and efficacy of the Spiration Valve System with optimal medical management.
...
In addition to lowering the number of monthly migraine days, galcanezumab may also reduce the need for acute medication in patients with migraine. A new post-hoc analysis presented at the American Headache...
In a phase 2b/3 study, a new orally administered CGRP receptor antagonist showed positive results in preventing migraines. Results were presented at the American Headache Society’s 61st Annual Scientific...
